TY - JOUR
T1 - The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer
T2 - a case of osteolytic prostate metastasis
AU - Tabrizipour, Amir I.ravani
AU - Dunne, Marina
PY - 2015/5/1
Y1 - 2015/5/1
N2 - We present the case of a 60-year-old male patient with T3b-N1, Gleason score 8, adenocarcinoma prostate with biochemical relapse (prostate-specific antigen, 5.2 μg/L) 1 year after radical treatment with 50.4-Gy 3-dimensional conformal radiotherapy and androgen deprivation therapy. Conventional imaging including contrast-enhanced abdominal CT and whole-body bone scintigraphy did not reveal any local recurrence or distant metastases. F-flourocholine PET/CT demonstrated a solitary, intensely avid (SUVmax, 9.2) osteolytic metastasis in the manubrium. Histopathology confirmed metastatic prostate adenocarcinoma.
AB - We present the case of a 60-year-old male patient with T3b-N1, Gleason score 8, adenocarcinoma prostate with biochemical relapse (prostate-specific antigen, 5.2 μg/L) 1 year after radical treatment with 50.4-Gy 3-dimensional conformal radiotherapy and androgen deprivation therapy. Conventional imaging including contrast-enhanced abdominal CT and whole-body bone scintigraphy did not reveal any local recurrence or distant metastases. F-flourocholine PET/CT demonstrated a solitary, intensely avid (SUVmax, 9.2) osteolytic metastasis in the manubrium. Histopathology confirmed metastatic prostate adenocarcinoma.
UR - http://www.scopus.com/inward/record.url?scp=85027955305&partnerID=8YFLogxK
U2 - 10.1097/RLU.0000000000000681
DO - 10.1097/RLU.0000000000000681
M3 - Article
C2 - 25608148
AN - SCOPUS:85027955305
SN - 0363-9762
VL - 40
SP - e285-e286
JO - Clinical nuclear medicine
JF - Clinical nuclear medicine
IS - 5
ER -